| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f7973eef9eb5bd10fb77b7f5e63f287
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c1ec2501b5be4a48e611f0432222962
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e61cfb51fa2b44c437821e74916283f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28ec47d39b45c74f7d7bfc1f8f3bc6ee |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 |
| filingDate |
2007-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71d764acc5ea4e85abb9b88cf23fbccc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f0e57cbc3f118e00ccaa9923fcb98db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3f6eb2fbedcfd237834be93ed80970c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e526859379836fe1a58ffcb23627c298
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_627f3791a2173dff432e92e8550c0877
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c29ede5a652d422e163fa7b5ebd7a45d |
| publicationDate |
2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-PI0716811-B8 |
| titleOfInvention |
anti-human folate alpha receptor antibodies, uses and method of production thereof, cocktail thereof, expression vector, host microorganism, pharmaceutical composition and combination, and method for diagnosing or reproducing images of ovarian carcinoma or its metastases |
| abstract |
human anti-folate alpha receptor antibodies and antibody fragments for radioimmunotherapy of ovarian carcinoma. The present invention relates to an antibody or fragment thereof, which specifically binds to the folate alpha receptor (fra), wherein said antibody or fragment thereof comprises a light chain whose variable region comprises at least one of the following amino acid sequences : - rasesvsflginlih (seq id no: 3), - qasnkot (seq id no: 4), - lqsknfppyt (seq id no: 5), and where the constant region of said light chain is a kappa constant region. |
| priorityDate |
2006-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |